342 results on '"Strassl, Robert"'
Search Results
52. The natural killer cell‐associated rs9916629 ‐ C allele is a novel genetic risk factor for fatal COVID‐19
53. Performance Evaluation of the Fully Automated NeuMoDx RT-PCR Platform for the Quantification of CMV and EBV DNA in EDTA Plasma: Implications for Clinical Management and Establishment of a Conversion Formula
54. Viral infections in pediatric brain tumor patients treated with targeted therapies
55. Serum Level of IP-10 Increases Predictive Value of IL28B Polymorphisms for Spontaneous Clearance of Acute HCV Infection
56. SARS-CoV-2 IgG spike protein antibody response in mRNA-1273 Moderna® vaccinated patients on maintenance immunoapheresis – a cohort study
57. HCV hotline facilitates Hepatitis C elimination during the COVID ‐19 pandemic
58. Increasing test specificity without impairing sensitivity: lessons learned from SARS-CoV-2 serology
59. Adult Respiratory Syncytial Virus Infection and Hypoxic Cardiac Arrest—Coexistent or Causal? A Hypothesis-Generating Case Report
60. The Systemic Renin-Angiotensin System in COVID-19
61. Incidence, phenotype and prognostic relevance of COVID-19-related liver injury across different age strata
62. Humoral Response to mRNA-1273 SARS-CoV-2 Vaccine in Peritoneal Dialysis Patients: Is Boostering After Six Months Adequate?
63. Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID‐19 in patients with chronic liver disease
64. Results of a SARS-CoV-2 virus genome detection external quality assessment round focusing on sensitivity of assays and pooling of samples
65. Age‐adjusted mortality and predictive value of liver chemistries in a Viennese cohort of COVID‐19 patients
66. MO1022: Torque Teno Virus Load in Kidney Transplantation: Association with Donor and Recipient Characteristics and Clinical Follow-Up Data
67. Early Estimated Glomerular Filtration Rate Trajectories After Kidney Transplant Biopsy as a Surrogate Endpoint for Graft Survival in Late Antibody-Mediated Rejection
68. Impact of HIV infection and antiretroviral treatment on N-terminal prohormone of brain natriuretic peptide as surrogate of myocardial function
69. Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Detection Tests Using Oral, Anterior Nasal, and Nasopharyngeal Swabs: a Diagnostic Accuracy Study
70. Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral Suppression
71. Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients
72. Saliva Sampling for Prospective SARS-CoV-2 Screening of Healthcare Professionals
73. Clinical Relevance of Absolute BK Polyoma Viral Load Kinetics in Patients With Biopsy Proven BK Polyomavirus Associated Nephropathy
74. Humoral Immune Response in Hematooncological Patients and Health Care Workers Who Received SARS-CoV-2 Vaccinations
75. Micro RNAs mir-106a, mir-122 and mir-197 are increased in severe acute viral hepatitis with coagulopathy
76. Prophylactic CMV therapy does not improve three-yr patient and graft survival compared to preemptive therapy
77. The natural killer cell‐associated rs9916629‐C allele is a novel genetic risk factor for fatal COVID‐19.
78. Viral infections in pediatric brain tumor patients treated with targeted therapies.
79. Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients – the Vienna Cohort
80. Therapeutic Potential of and Treatment with Boceprevir/Telaprevir-Based Triple-Therapy in HIV/Chronic Hepatitis C Co-Infected Patients in a Real-World Setting
81. Identification of Immune Activation Markers in the Early Onset of COVID-19 Infection
82. Torque Teno Virus Load Is Associated With Subclinical Alloreactivity in Kidney Transplant Recipients: A Prospective Observational Trial
83. Epidemiological trends of HBV and HDV coinfection among Viennese HIV+ patients
84. Analysis of the specificity of a COVID-19 antigen test in the Slovak mass testing program
85. ACE2 Elevation in Severe COVID-19
86. A Longitudinal Seroprevalence Study Evaluating Infection Control and Prevention Strategies at a Large Tertiary Care Center with Low COVID-19 Incidence
87. Increasing test specificity without impairing sensitivity: lessons learned from SARS-CoV-2 serology
88. SARS-CoV-2 IgG spike protein antibody response in mRNA1273 Moderna® vaccinated patients on maintenance immunoapheresis – a cohort study.
89. Hemophagocytic lymphohistiocytosis in COVID-19
90. Respiratory syncytial virus infection is an underestimated cause of viral pneumoniae in adults
91. A comprehensive antigen production and characterization study for easy-to-implement, highly specific and quantitative SARS-CoV-2 antibody assays
92. SARS-CoV-2 Postvaccination Infections Among Staff Members of a Tertiary Care University Hospital – Vienna, January-July 2021; an Exploratory Study on 8 500 Employees with Better Outcome of Vector than m-RNA Vaccine
93. Detection of SARS-CoV-2 by Real-Time PCR under challenging pre-analytical conditions reveals independence of swab media and cooling chain
94. Analysis of the specificity of the SD Biosensor Standard Q Ag-Test based on Slovak mass testing data
95. COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease
96. Increasing test specificity without impairing sensitivity - lessons learned from SARS-CoV-2 serology
97. Side-by-Side Comparison of Three Fully Automated SARS-CoV-2 Antibody Assays with a Focus on Specificity
98. SARS-CoV-2 Testing in Patients With Cancer Treated at a Tertiary Care Hospital During the COVID-19 Pandemic
99. Lung transplantation for COVID-19-associated acute respiratory distress syndrome in a PCR-positive patient
100. Recent outbreaks of severe hepatitis A virus infections in Vienna
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.